On the disposition of de novo synthesized quinolinic acid in rat brain tissue.

[1]  U. Ungerstedt,et al.  Production of extracellular quinolinic acid in the striatum studied by microdialysis in unanesthetized rats , 1989, Neuroscience Letters.

[2]  R. Schwarcz,et al.  Basal ganglia lesions in the rat: effects on quinolinic acid metabolism , 1989, Brain Research.

[3]  T. Stone,et al.  NMDA receptors and ligands in the vertebrate CNS , 1988, Progress in Neurobiology.

[4]  R. Schwarcz,et al.  Localization of quinolinic acid metabolizing enzymes in the rat brain. immunohistochemical studies using antibodies to 3-hydroxyanthranilic acid oxygenase and quinolinic acid phosphoribosyltransferase , 1988, Neuroscience.

[5]  R. Schwarcz,et al.  A radioenzymatic assay for quinolinic acid. , 1986, Analytical biochemistry.

[6]  L. Iversen,et al.  The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Schwarcz,et al.  Synthesis of Quinolinic Acid by 3‐Hydroxyanthranilic Acid Oxygenase in Rat Brain Tissue In Vitro , 1986, Journal of neurochemistry.

[8]  R. Schwarcz,et al.  II: Excitotoxic models for neurodegenerative disorders , 1984 .

[9]  T. Hökfelt,et al.  Ibotenic acid-induced neuronal degeneration: A morphological and neurochemical study , 1979, Experimental Brain Research.

[10]  R. Schwarcz,et al.  Preparation of 4-halo-3-hydroxyanthranilates and demonstration of their inhibition of 3-hydroxyanthranilate oxygenase activity in rat and human brain tissue. , 1989, Preparative Biochemistry.